NRG Oncology — Philadelphia, Pennsylvania

NRG Oncology is a clinical research site located in Philadelphia, Pennsylvania, United States 19103.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

NRG Oncology has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NRG Oncology?

NRG Oncology has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NRG Oncology conducted?

NRG Oncology has 2 clinical trials on record, with 2 currently active. Their work covers Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma.

Is NRG Oncology accredited by Crixeo Health?

NRG Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NRG Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.